HERSHBERG ROBERT (CIK 1274139) reported 13 SEC Form 4 insider transactions across 4 companies over the past 18 months (most recent 2026-08-20). Recent activity: Buy ADPT (15,000 shares), Sell ADPT (15,000 shares), Sell ADPT (15,664 shares), Buy ATAI (48,858 shares), Buy ATAI (51,142 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-20 | Adaptive Biotechnologies Corp (ADPT) | Director | Buy | 15,000 | $94,800 |
| 2026-08-20 | Adaptive Biotechnologies Corp (ADPT) | Director | Sell | 15,000 | $365,850 |
| 2026-08-20 | Adaptive Biotechnologies Corp (ADPT) | Director | Sell | 15,664 | $382,358 |
| 2026-07-09 | AtaiBeckley Inc. (ATAI) | Director | Buy | 48,858 | $65,958 |
| 2026-07-09 | AtaiBeckley Inc. (ATAI) | Director | Buy | 51,142 | $69,042 |
| 2026-07-09 | AtaiBeckley Inc. (ATAI) | Director | Sell | 100,000 | $496,000 |
| 2026-06-22 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | Buy | 88,424 | $0 |
| 2026-03-06 | Adaptive Biotechnologies Corp (ADPT) | Director | Buy | 15,625 | $0 |
| 2025-12-12 | Adaptive Biotechnologies Corp (ADPT) | Director | Sell | 22,968 | $367,488 |
| 2025-09-17 | HilleVax, Inc. (HLVX) | President and CEO | Sell | 1.1M | $0 |
| 2025-06-23 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | Buy | 22,016 | $0 |
| 2025-03-12 | Adaptive Biotechnologies Corp (ADPT) | Director | Sell | 53,000 | $402,270 |
| 2025-03-06 | Adaptive Biotechnologies Corp (ADPT) | Director | Buy | 15,394 | $0 |
Source: SEC Form 4 filings · as of 2026-08-20